Cargando…

Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study

Patients with multiple sclerosis (MS) often complain of urinary disturbances characterized by overactive bladder syndrome and difficulties in bladder emptying. The aim of the study was to investigate the pathophysiology of bladder dysfunction and the neurophysiological effects of intradetrusorial in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conte, Antonella, Giannantoni, Antonella, Gubbiotti, Marilena, Pontecorvo, Simona, Millefiorini, Enrico, Francia, Ada, Porena, Massimo, Berardelli, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591651/ https://www.ncbi.nlm.nih.gov/pubmed/26343721 http://dx.doi.org/10.3390/toxins7093424

Ejemplares similares

Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis
por: Giannantoni, Antonella, et al.
Publicado: (2019)

Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia
por: Costanzo, Matteo, et al.
Publicado: (2021)

Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: A pilot study
por: Gubbiotti, Marilena, et al.
Publicado: (2019)

Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias
por: De Bartolo, Maria Ilenia, et al.
Publicado: (2020)

Resilience in the face of pelvic pain: A pilot study in males and females affected by urologic chronic pelvic pain
por: Giannantoni, Antonella, et al.
Publicado: (2021)

Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study
por: Tartaglia, Matteo, et al.
Publicado: (2023)

The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
por: Gubbiotti, Marilena, et al.
Publicado: (2019)

Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?
por: Belvisi, Daniele, et al.
Publicado: (2022)

Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence
por: Conte, Antonella, et al.
Publicado: (2020)

Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation
por: Iannetta, Marco, et al.
Publicado: (2016)

Longitudinal study of clinical and neurophysiological features in essential tremor
por: Angelini, Luca, et al.
Publicado: (2022)

Frontotemporal dementia: a neurophysiological study
por: Di Stasio, Flavio, et al.
Publicado: (2018)

Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations
por: Alimohammadi, Mohammad, et al.
Publicado: (2017)

The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer
por: Amantini, Consuelo, et al.
Publicado: (2022)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Time to onset and duration of botulinum toxin efficacy in movement disorders
por: Ledda, Claudia, et al.
Publicado: (2022)

Clinical neurophysiology of Parkinson’s disease and parkinsonism
por: Chen, Robert, et al.
Publicado: (2022)

Effects of botulinum toxin injection on systemic sclerosis-related digital ulcers
por: Souk, Jin-Woo, et al.
Publicado: (2019)

Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis
por: Manrique, Dayse
Publicado: (2015)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Correlation between High PD-L1 and EMT/Invasive Genes Expression and Reduced Recurrence-Free Survival in Blood-Circulating Tumor Cells from Patients with Non-Muscle-Invasive Bladder Cancer
por: Morelli, Maria Beatrice, et al.
Publicado: (2021)

A nationwide survey on clinical neurophysiology education in Italian schools of specialization in neurology
por: Bocci, Tommaso, et al.
Publicado: (2021)

Botulinum toxin A modifies nociceptive withdrawal reflex in subacute stroke patients
por: Alvisi, Elena, et al.
Publicado: (2018)

Botulinum toxin A modifies nociceptive withdrawal reflex in subacute stroke patients
por: Alvisi, Elena, et al.
Publicado: (2018)

Toxin yet not toxic: Botulinum toxin in dentistry
por: Archana, M.S.
Publicado: (2016)

Intensive therapy after botulinum toxin in adults with spasticity after stroke versus botulinum toxin alone or therapy alone: a pilot, feasibility randomized trial
por: Lannin, Natasha A., et al.
Publicado: (2018)

Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009)

Botulinum toxin: The Midas touch
por: Shilpa, P. S., et al.
Publicado: (2014)

Wound Modulation with Botulinum Toxin
por: Malik, Archana, et al.
Publicado: (2016)

Botulinum Toxin in the Treatment of Headache
por: Becker, Werner J.
Publicado: (2020)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

Botulinum Toxin for Scalp Dysesthesia
por: Phan, Kevin, et al.
Publicado: (2022)

Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022)

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
por: Valente, Mariarosaria, et al.
Publicado: (2021)

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022)

Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study
por: Baccouche, Ines, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rf7du9ehng4itfmrq9bo2ea4oe